Anti-cancerous efficacy and pharmacokinetics of 6-mercaptopurine loaded chitosan nanoparticles

被引：31
|
作者：
Kumar, G. Prem [1 ,2 ]
Sanganal, Jagadeesh S. [2 ]
Phani, A. R. [3 ]
Manohara, C. [2 ]
Tripathi, Syamantak M. [4 ]
Raghavendra, H. L. [5 ]
Janardhana, P. B. [6 ]
Amaresha, S. [2 ]
Swamy, K. B. [2 ]
Prasad, R. G. S. V. [7 ]
机构：
[1] Bioneeds India Private Ltd, Dept Toxicol, Bangalore, Karnataka, India
[2] Vet Coll, Dept Vet Pharmacol & Toxicol, Bangalore, Karnataka, India
[3] Nano Res Adv Mat & Technol, Bangalore, Karnataka, India
[4] Coll Vet Sci & Anim Husb, Durg, Chhattisgarh, India
[5] Wollega Univ, Coll Med & Hlth Sci, Sch Med, Nekemte, Ethiopia
[6] Stellixir Biotech Private Ltd, Bangalore, Karnataka, India
[7] Asian Metropolitan Univ, Fac Pharmaceut Sci, Selangor, Kualalumpur, Malaysia
来源：
PHARMACOLOGICAL RESEARCH | 2015年 / 100卷
关键词：
Chitosan nanoparticles; Cytotoxic; Apoptosis; ROS and bioavailability; ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL-CYCLE; IN-VIVO; DRUG; MERCAPTOPURINE; DERIVATIVES; PROGRESSION; ABROGATION; HYDROGELS; DESIGN;
D O I：
10.1016/j.phrs.2015.07.025
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
6-Mercaptopurine is a cytotoxic and immunosuppressant drug. The use of this drug is limited due to its poor bioavailability and short plasma half-life. In order to nullify these drawbacks, 6-mercaptopurine-chitosan nanoparticles (6-MP-CNPs) were prepared and evaluated to study the influence of preparation conditions on the physicochemical properties by using DLS, SEM, XRD and FTIR. The in vitro drug release profile at pH 4.8 and 7.4 revealed sustained release patterns for a period of 2 days. The nanoformulations showed enhanced in vitro anti-cancer activities (MU assay, apoptosis assay, cell cycle arrest and ROS indices) on HT-1080 and MCF-7 cells. In vivo pharmacokinetics profiles of 6-MP-CNPs showed improved bioavailability. Thus, the results of the present study revealed that, the prepared 6-MP-CNPs have a significant role in increasing anti-cancer efficacy, bioavailability and in vivo pharmacokinetics profiles. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码：47 / 57
页数：11
相关论文
共 50 条
  • [31] THE THERAPEUTIC EFFICACY OF 6-MERCAPTOPURINE IN REFRACTORY ULCERATIVE-COLITIS
    ADLER, DJ
    KORELITZ, BI
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1990, 85 (06): : 717 - 722
  • [32] CLINICAL STUDIES ON ANTI-INFLAMMATORY ACTIVITY OF 6-MERCAPTOPURINE
    PAGE, AR
    GOOD, RA
    CONDIE, RM
    BLOOD, 1962, 20 (01) : 118 - &
  • [33] HOW IMPORTANT ARE THE VARIABLE PHARMACOKINETICS OF 6-MERCAPTOPURINE (6-MP) IN THE THERAPY OF ALL
    LILLEYMAN, JS
    LENNARD, L
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 385 - 385
  • [34] EFFICACY OF 6-MERCAPTOPURINE (6MP) IN REFRACTORY ULCERATIVE-COLITIS
    PRESENT, DH
    CHAPMAN, ML
    RUBIN, PH
    GASTROENTEROLOGY, 1988, 94 (05) : A359 - A359
  • [35] Lower doses of 6-mercaptopurine/azathioprine bring enough clinical efficacy and therapeutic concentration of erythrocyte 6-mercaptopurine metabolite in Japanese IBD patients
    Komiyama, Takako
    Yajima, Tomoharu
    Kubota, Rie
    Iwao, Yasushi
    Sakuraba, Atsushi
    Funakoshi, Shinsuke
    Negishi, Kenichi
    Minami, Ikuko
    Tanaka, Yoichi
    Mae, Hiroshi
    Hibi, Toshifumi
    JOURNAL OF CROHNS & COLITIS, 2008, 2 (04): : 315 - 321
  • [36] PHARMACOKINETICS OF ELIMINATION OF 6-MERCAPTOPURINE IN THE URINE OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    HERMANN, T
    CHRZANOWSKA, M
    MICHALEWSKA, D
    SKIBINSKA, L
    POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1985, 37 (02): : 209 - 216
  • [37] Improvement of 6 Mercaptopurine Efficiency by Encapsulated in Chitosan Nanoparticles
    Hussein, Amna
    Badr, Y. A.
    Shouman, Samia A.
    Sliem, Mahmoud A.
    ARAB JOURNAL OF NUCLEAR SCIENCES AND APPLICATIONS, 2018, 51 (04): : 181 - 186
  • [38] EFFECT OF ALLOPURINOL ON PHARMACOKINETICS OF 6-MERCAPTOPURINE (NSC 755) IN CANCER-PATIENTS
    COFFEY, JJ
    SERPICK, AA
    WHITE, CA
    ROGERS, WI
    LESK, AB
    CANCER RESEARCH, 1972, 32 (06) : 1283 - &
  • [39] Pharmacokinetics of two 6-mercaptopurine liquid formulations in children with acute lymphoblastic leukemia
    Tolbert, Jaszianne A.
    Bai, Shasha
    Abdel-Rahman, Susan M.
    August, Keith J.
    Weir, Scott J.
    Kearns, Gregory L.
    Neville, Kathleen A.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (08)
  • [40] Concanavalin-A conjugated fine-multiple emulsion loaded with 6-mercaptopurine
    Khopade, AJ
    Jain, NK
    DRUG DELIVERY, 2000, 7 (02) : 105 - 112
12345